FDA Warns Against Zicam Cold Medicines

Recently the United States Food and Drug Administration (FDA), has been warning all consumers to immediately stop using and dispose of three types of the Zicam intranasal products, Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Nasal Swabs, and Zicam Cold Remedy Swabs, Kids Size. The warning came after more than 130 reports claiming a loss of smell after the use of the products. Anosmia, the loss of the sense of smell, may be long-lasting or even permanent in some cases.

Obviously the loss of smell can have a very negative impact on a person’s life. The agency says that the loss of sense of smell can adversely affect a person’s quality of life, and can limit the ability to detect the smell of gas or smoke or other signs of danger in the environment.

The first reports of the loss of smell due to the use of Zicam products were back in 1999. Furthermore, in many reports the loss of smell occurred after the first dose. However, some reports said that the loss of the sense of smell occurred after multiple uses. Matrixx agreed to pay $12 million to settle the claims of 340 plaintiffs in 2006, all of which said they had lost their sense of smell.

Even today Matrixx is facing lawsuits due to the products, but goes on to say on their Website, “No plaintiff has ever won a court case, because there is no known causal link between the use of Zicam Cold Remedy nasal gel and impairment of smell.”

The FDA is advising anyone experiencing a loss of their sense of smell, or any other problem, to immediately contact their health care provider. Physicians and consumers are also encouraged to report adverse events that may be related to the use of these products to the FDA’s MedWatch Adverse Event Reporting program online, by regular mail, fax or phone.

– Online
– Regular mail: MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787
– Fax: 800-FDA-0178
– Phone: 800-FDA-1088